Filing Details
- Accession Number:
- 0001012975-15-000295
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-04-16 11:16:58
- Reporting Period:
- 2015-04-07
- Filing Date:
- 2015-04-16
- Accepted Time:
- 2015-04-16 11:16:58
- Original Submission Date:
- 2015-04-09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1319446 | Alexis Borisy | C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-04-07 | 241,768 | $50.00 | 48,867 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This amended Form 4 represents the final number of shares sold by the reporting person in connection with the tender offer for shares of Common Stock of the Issuer (the "Tender Offer") by Roche Holdings, Inc. The final proration factor for the Tender Offer is 83.2%.